RN7SKP135

Across TCGA pan-cancer cohorts, RN7SKP135 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RN7SKP135 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RN7SKP135 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP135 expression acts as an unfavorable survival marker.

STAD, ESCA, and LGG are the cancer types where RN7SKP135 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.444	0.740	.010	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
LGG	OS	Tertile	All	0.021	0.896	<.001	36	view →
OV	OS	Tertile	IV	0.059	0.759	.006	36	view →
HNSC	OS	Tertile	All	0.191	0.710	.021	18	view →
KIRC	OS	Tertile	All	0.318	0.661	.016	12	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RN7SKP135–STAD (OS)

Open the STAD breakdown →